Endovascular Treatment of Thoracic Aortic Disease
Enrolling by invitation · Not applicable
Conditions studied: Thoracic Aortic Aneurysms, Dissecting, Aneurysm, Ascending Aorta Aneurysm, Aortic Arch; Aneurysm, Dissecting, Ascending Aortic Dissection, Thoracoabdominal Aortic Aneurysm, Renal Artery Aneurysm, Superior Mesenteric Artery Aneurysm, Aortic Dissection
In brief
The purpose of this study is to assess the role endovascular therapy to treat aortic disease involving the ascending aorta, the aortic arch, and the visceral segment of the aorta (or thoracoabdominal aorta)
Key facts
- Study ID
- NCT00583817
- Run by
- Matthew Eagleton
- People needed
- 170
- Starts
- 2018-10-25
- Expected to finish
- 2030-12-01
- Last updated by the study team
- 2026-05-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.